IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Clinical trial NCT04982705 · UNKNOWN

Trial details

NCT number: NCT04982705
Sponsor: IlDong Pharmaceutical Co Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-07-07
Primary completion: 2022-11-09
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.